Close
Smartlab Europe
Inizio Ignite

News

Glenmark completes PMS study of Covid-19 drug Favipiravir

Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India. The PMS study commenced in July 2020 to evaluate the safety and efficacy of Favipiravir...

EUA for Lilly’s bamlanivimab and etesevimab administered together expanded to include post-exposure prophylaxis for COVID-19

The U.S. FDAhas expanded the Emergency Use Authorization (EUA) for bamlanivimab 700 mg and etesevimab 1400 mg administered together to include post-exposure prophylaxis (PEP) in certain individuals for the prevention of SARS-CoV-2 infection, Eli Lilly and Company (NYSE: LLY)...

LANXESS India wins big at the Indian Chemical Council awards

Specialty chemicals company LANXESS India has been conferred with three prestigious awards from the Indian Chemical Council (ICC), recognizing the organization’s commitment and outstanding performance specifically in the areas of Health & Safety. LANXESS India won awards for Excellence...

BMG Pharma and HTL sign a development agreement to manufacture BMG’s new biopolymer based on the Hyaluromimethic Technology

BMG Pharma – a biotech and B2B company headquartered in Milan with its chemical plant in Torviscosa (Italy) that exports its medical products to more than 80 countries – has signed a development and commercial agreement with HTL, a...

Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK and Singapore

Astrea Bioseparations, a leading provider of bioseparations products and services, announced two new investments to enhance operations and customer support resources. The investments include an expansion of the company’s research and development facility in Cambridge, United Kingdom to add...

Propofol production at Bachem why it has been a success

The COVID-19 pandemic has rapidly expanded awareness of the API Propofol, produced by Bachem in Vionnaz. We are both pleased by, and proud of, Bachem’s prompt response to sharply higher demand. Based on a prudent business continuity management plan, our...

Veramed appoints Alexander Schacht to lead new Launch & Commercialisation business unit

Veramed, one of the UK’s fastest growing Contract Research Organisations (CRO) providing specialist statistics and programming services to the bio-pharmaceutical industry, has appointed Alexander Schacht as Executive VP of Launch and Commercialisation Data Sciences to spearhead the company’s new...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »